Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0R95
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,146
Award facts
- Contract value 100% obligated
- $17,145.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $17,145.94, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract (IDC) that DMS Pharmaceutical Group secured on November 13, 2025, with a $499.999 billion ceiling. This delivery order represents one of numerous firm fixed-price orders being issued to the contractor to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities. No set-aside designation was used for this award, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group's product portfolio encompasses a comprehensive range of pharmaceuticals including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals critical to military medical operations. The PPV-G GEN V program is part of DLA's broader $30.3 billion acquisition strategy to establish regional prime vendor contractors capable of supporting recurring pharmaceutical and medical supply needs across the global Defense medical system. The contractor's registration in the System for Award Management since 2001 and demonstrated performance on substantial federal contracting activity position it as an established supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DU26F0R95?
SPE2DU26F0R95 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DU26F0R95 worth?
The government has obligated $17,146 on SPE2DU26F0R95.
Is contract SPE2DU26F0R95 an order under another contract?
Yes. SPE2DU26F0R95 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0R95 competed?
The extent of competition for SPE2DU26F0R95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award